Delivery Order SPE2DB22D2007-SPE2DB26FH6MY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.29 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on October 16, 2025, with a completion deadline of November 6, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price arrangement. The award was made on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a non-set-aside competitive award, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of OFEV 150 mg capsules (60 count units) valued at $8,591. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The order is scheduled for completion by November 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 for OFEV 150 mg capsule 60-count units on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of OFEV 150 mg capsules (60 count) with a ceiling value of $8,590.58. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of OFEV 150 mg capsules in quantities of 60 units. This firm fixed price delivery order, valued at $8,590.58, is scheduled for completion by October 20, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $8,590.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on October 21, 2025, with completion targeted for November 12, 2025. This non-set-aside contract represents a delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's distribution...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,630.28 for OFEV 100 mg capsules (60-count units) on August 6, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,590.58 by the Defense Logistics Agency to supply OFEV 150 mg capsules (60-count units). The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, utilizes firm fixed-price pricing under a competitive, non-set-aside contract. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6MYDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,181.16 for OFEV 150 mg capsules (60-count units) with a completion deadline of November 18, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the Defense Logistics Agency's medical supply chain, supporting military healthcare operations and veteran services. As a major prime contractor under the DLA Troop Support Medical IDC, AmerisourceBergen routinely fulfills delivery orders for branded and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic areas. The company's competitive position within the federal pharmaceutical procurement landscape is demonstrated through its extensive contract portfolio with DLA and its capability to meet firm fixed pricing requirements for diverse medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 10/27/25 |